Impedimed Ltd
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue compositi… Read more
Impedimed Ltd (IPD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -1.053x
Based on the latest financial reports, Impedimed Ltd (IPD) has a cash flow conversion efficiency ratio of -1.053x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.50 Million) by net assets (AU$9.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Impedimed Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Impedimed Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Impedimed Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Impedimed Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aztec Minerals Corp
OTCQB:AZZTF
|
-0.011x |
|
ANKM
OTCQB:ANKM
|
-0.546x |
|
PINE Technology Holdings Limited
F:PNY
|
0.044x |
|
Liberty Shoes Limited
NSE:LIBERTSHOE
|
0.117x |
|
Cho Kwang Pain
KO:004910
|
0.016x |
|
STRAN + CO.INC. DL -0001
F:S9H
|
N/A |
|
Critical Holdings Berhad
KLSE:0291
|
0.149x |
|
Era Media Sejahtera
JK:DOOH
|
0.033x |
Annual Cash Flow Conversion Efficiency for Impedimed Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Impedimed Ltd from 2008 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$20.50 Million | AU$-14.64 Million | -0.715x | -63.65% |
| 2024-06-30 | AU$40.74 Million | AU$-17.79 Million | -0.437x | -47.27% |
| 2023-06-30 | AU$60.88 Million | AU$-18.05 Million | -0.296x | +3.39% |
| 2022-06-30 | AU$51.04 Million | AU$-15.66 Million | -0.307x | +40.94% |
| 2021-06-30 | AU$25.51 Million | AU$-13.26 Million | -0.520x | +26.02% |
| 2020-06-30 | AU$27.36 Million | AU$-19.22 Million | -0.702x | +43.40% |
| 2019-06-30 | AU$15.79 Million | AU$-19.59 Million | -1.241x | -89.40% |
| 2018-06-30 | AU$35.80 Million | AU$-23.46 Million | -0.655x | -50.68% |
| 2017-06-30 | AU$58.80 Million | AU$-25.57 Million | -0.435x | -65.33% |
| 2016-06-30 | AU$85.25 Million | AU$-22.42 Million | -0.263x | +14.83% |
| 2015-06-30 | AU$34.84 Million | AU$-10.76 Million | -0.309x | +38.57% |
| 2014-06-30 | AU$13.53 Million | AU$-6.80 Million | -0.503x | +30.62% |
| 2013-06-30 | AU$10.59 Million | AU$-7.67 Million | -0.724x | -6.30% |
| 2012-06-30 | AU$17.31 Million | AU$-11.80 Million | -0.682x | -24.75% |
| 2011-06-30 | AU$20.68 Million | AU$-11.30 Million | -0.546x | -16.93% |
| 2010-06-30 | AU$22.23 Million | AU$-10.39 Million | -0.467x | +60.09% |
| 2009-06-30 | AU$10.07 Million | AU$-11.79 Million | -1.171x | -94.18% |
| 2008-06-30 | AU$12.30 Million | AU$-7.42 Million | -0.603x | -- |